0 citations
Azvudine and Nirmatrelvir–Ritonavir in Hospitalised Patients with Moderate–To–Severe COVID–19: Emulation of a Randomised Target Trial
SSRN Electronic Journal2023
Citations Over Time
Yiling Zhou, Yi Liu, Li Jiang, Renqing Zhang, Huohuo Zhang, Qingyang Shi, Zhirong Yang, Yi Mao, Sha Liu, Zhibo Yang, Jialin Ding, Yongzhao Zhou, Bi Ren, Liping He, Xing Zhao, Weimin Li, Sheyu Li, Dan Liu
Related Papers
- → The SARS‐CoV‐2 omicron wave is indicating the end of the pandemic phase but the COVID‐19 will continue(2022)62 cited
- → Suggesting Ritonavir against COVID-19/SARS-CoV-2(2020)3 cited
- → ОПЫТ ИССЛЕДОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ К ВИРУСУ SARS-CoV-2 НАСЕЛЕНИЯ ИРКУТСКОЙ ОБЛАСТИ В ПЕРИОД ВСПЫШКИ COVID-19(2020)2 cited
- → COVID-19 vaccines and appearance of SARS-CoV-2 variants. Reflecting on the case of Mexico(2021)1 cited
- Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19. (Special Issue: New coronavirus (2019-nCoV or SARS-CoV-2) and the outbreak of the respiratory illness (COVID-19): Part-XI.)(2020)